|
RPL35 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.709830E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.635970E-01 |
| Normal-vs-Stage2 |
9.995200E-01 |
| Normal-vs-Stage3 |
8.880200E-02 |
| Normal-vs-Stage4 |
2.961200E-01 |
| Stage1-vs-Stage2 |
3.085400E-01 |
| Stage1-vs-Stage3 |
3.501600E-01 |
| Stage1-vs-Stage4 |
9.979400E-01 |
| Stage2-vs-Stage3 |
1.293020E-01 |
| Stage2-vs-Stage4 |
3.779400E-01 |
| Stage3-vs-Stage4 |
5.484800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.105410E-01 |
| Normal-vs-AfricanAmerican |
7.581600E-01 |
| Normal-vs-Asian |
2.661600E-01 |
| Caucasian-vs-AfricanAmerican |
1.310200E-01 |
| Caucasian-vs-Asian |
9.693000E-01 |
| AfricanAmerican-vs-Asian |
2.040200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.550400E-01 |
| Normal-vs-Female |
2.095200E-01 |
| Male-vs-Female |
7.981200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.984000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.237000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.504600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.834000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.663200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.080000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.457200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.481600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.613600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.825400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.511600E-01 |
| Classical-VS-Follicular |
7.640600E-01 |
| Classical-VS-Other |
6.209400E-01 |
| Classical-VS-Normal |
2.441800E-01 |
| Tall-VS-Follicular |
4.808000E-01 |
| Tall-VS-Other |
9.205000E-01 |
| Tall-VS-Normal |
9.865700E-02 |
| Follicular-VS-Other |
5.781400E-01 |
| Follicular-VS-Normal |
2.845000E-01 |
| Other-VS-Normal |
3.606800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.403400E-01 |
| Normal-vs-N1 |
1.002380E-01 |
| N0-vs-N1 |
4.631600E-01 |
|
|
